1. Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly. Issue 6383 (25th June 1983) Authors: Besser, G M; Rees, L H; Wass, J A; Savage, M O; Grossman, A; Lytras, N Journal: BMJ Issue: Volume 286:Issue 6383(1983) Page Start: 2063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absence of uterine neoplasia in patients on bromocriptine. Issue 6091 (1st October 1977) Authors: Besser, G M; Thorner, M O; Wass, J A; Doniach, I; Canti, G; Curling, M; Grudziniskas, J G; Setchell, M E Journal: BMJ Issue: Volume 2:Issue 6091(1977) Page Start: 868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Apathetic T-3 toxicosis. Issue 5904 (2nd March 1974) Authors: Fairclough, P D; Besser, G M Journal: BMJ Issue: Volume 1:Issue 5904(1974) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bromocriptine and uterine neoplasia. Issue 6100 (3rd December 1977) Authors: Besser, G M Journal: BMJ Issue: Volume 2:Issue 6100(1977) Page Start: 1476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bromocriptine in management of large pituitary tumours. Issue 6333 (26th June 1982) Authors: Wass, J A; Williams, J; Charlesworth, M; Kingsley, D P; Halliday, A M; Doniach, I; Rees, L H; McDonald, W I; Besser, G M Journal: BMJ Issue: Volume 284:Issue 6333(1982) Page Start: 1908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bromocriptine in management of large pituitary tumours. Issue 6344 (18th September 1982) Authors: Wass, J A; Besser, G M; McDonald, W I Journal: BMJ Issue: Volume 285:Issue 6344(1982) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bromocriptine treatment of acromegaly. Issue 5953 (8th February 1975) Authors: Thorner, M O; Chait, A; Aitken, M; Benker, G; Bloom, S R; Mortimer, C H; Sanders, P; Mason, A S; Besser, G M Journal: BMJ Issue: Volume 1:Issue 5953(1975) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bromocriptine treatment of female infertility: report of 13 pregnancies. Issue 5998 (20th December 1975) Authors: Thorner, M O; Besser, G M; Jones, A; Dacie, J; Jones, A E Journal: BMJ Issue: Volume 4:Issue 5998(1975) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Issue 6443 (25th August 1984) Authors: Penny, E S; Penman, E; Price, J; Rees, L H; Sopwith, A M; Wass, J A; Lytras, N; Besser, G M Journal: BMJ Issue: Volume 289:Issue 6443(1984) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical evaluation of lysuride in the management of hyperprolactinaemia. Issue 6583 (23rd May 1987) Authors: Bouloux, P M; Besser, G M; Grossman, A; Moult, P J Journal: BMJ Issue: Volume 294:Issue 6583(1987) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗